Inhibitory Substrate Binding Site of Human Indoleamine 2,3-Dioxygenase

被引:79
作者
Lu, Changyuan [1 ]
Lin, Yu [1 ]
Yeh, Syun-Ru [1 ]
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA
关键词
TRYPTOPHAN-METABOLISM; EXIGUAMINE-A; OXYGEN; MECHANISM; ENZYMES; TARGET; IDO;
D O I
10.1021/ja9029768
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Human indoleamine 2,3-dioxygenase (hIDO) is an intracellular heme-containing enzyme, which catalyzes the initial and rate-determining step of L-tryptophan (L-Trp) metabolism via the kynurenine pathway. Due to its immunosuppressive function, hIDO has been recognized as an important drug target for cancer. Here we report evidence supporting the presence of an inhibitory substrate binding site (S-i) in hIDO that is capable of binding molecules with a wide variety of structures, including substrates (L-Trp and 1-methyl-L-tryptophan), an effector (3-indole ethanol), and an uncompetitive inhibitor (Mitomycin C). The data offer useful guidelines for future development of more potent hIDO inhibitors; they also call for the re-evaluation of the action mechanism of Mitomycin C (MtoC), a widely used antitumor chemotherapeutic agent.
引用
收藏
页码:12866 / +
页数:3
相关论文
共 22 条
[1]   Oxygen sensing and molecular adaptation to hypoxia [J].
Bunn, HF ;
Poyton, RO .
PHYSIOLOGICAL REVIEWS, 1996, 76 (03) :839-885
[2]   1-METHYL-DL-TRYPTOPHAN, BETA-(3-BENZOFURANYL)-DL-ALANINE (THE OXYGEN ANALOG OF TRYPTOPHAN), AND BETA-[3-BENZO(B)THIENYL]-DL-ALANINE (THE SULFUR ANALOG OF TRYPTOPHAN) ARE COMPETITIVE INHIBITORS FOR INDOLEAMINE 2,3-DIOXYGENASE [J].
CADY, SG ;
SONO, M .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 291 (02) :326-333
[3]   Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A [J].
Carr, Gavin ;
Chung, Marco K. W. ;
Mauk, A. Grant ;
Andersen, Raymond J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (09) :2634-2637
[4]  
Carter S.K., 1979, MITOMYCIN C
[5]   Reassessment of the Reaction Mechanism in the Heme Dioxygenases [J].
Chauhan, Nishma ;
Thackray, Sarah J. ;
Rafice, Sara A. ;
Eaton, Graham ;
Lee, Michael ;
Efimov, Igor ;
Basran, Jaswir ;
Jenkins, Paul R. ;
Mowat, Christopher G. ;
Chapman, Stephen K. ;
Raven, Emma Lloyd .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (12) :4186-+
[6]  
Copeland R. A., 2000, ENZYMES
[7]   Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses [J].
Hou, De-Yan ;
Muller, Alexander J. ;
Sharma, Madhav D. ;
DuHadaway, James ;
Banerjee, Tinku ;
Johnson, Maribeth ;
Mellor, Andrew L. ;
Prendergasts, George C. ;
Munn, David H. .
CANCER RESEARCH, 2007, 67 (02) :792-801
[8]  
ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593
[9]  
JONES DP, 1978, J BIOL CHEM, V253, P4874
[10]   Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors [J].
Kumar, Sanjeev ;
Malachowski, William P. ;
DuHadaway, James B. ;
LaLonde, Judith M. ;
Carroll, Patrick J. ;
Jaller, Daniel ;
Metz, Richard ;
Prendergast, George C. ;
Muller, Alexander J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) :1706-1718